Atinvicitinib
Product Specifications
CAS Number
2169273-59-8
Target
JAK
Related Pathways
JAK/STAT signaling, Chromatin/Epigenetic, Tyrosine Kinase/Adaptors, Angiogenesis, Stem Cells
Purity
0.9936
Bioactivity
Atinvicitinib, a selective Janus kinase (JAK) inhibitor, demonstrates high specificity for Janus kinase 1 (JAK1), consequently inhibiting downstream cytokine signaling pathways that rely on JAK1 enzymatic activity. Atinvicitinib modulates a wide range of cytokines that are implicated in itch responses, allergic reactions, and inflammatory conditions, making it a significant research tool for studying cytokine-mediated immune processes as well as therapeutic modulation of allergic and inflammatory diseases.
Smiles
COc1cc(Nc2nn(cc2C(N)=O)[C@H]2COCC[C@@H]2C#N)cc(F)n1
Molecular Formula
C16H17FN6O3
Molecular Weight
360.35
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15091536 1 Vial
Lentiviral human IRX3 shRNA (UAS) - Lentiviral human IRX3 shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details